Statins show promise for kids with kidney disease and high cholesterol
NCT ID NCT07497776
First seen Apr 20, 2026 · Last updated May 12, 2026 · Updated 4 times
Summary
This study tested the drug atorvastatin in 100 children aged 8-18 with steroid-sensitive nephrotic syndrome and high cholesterol. The goal was to see if the drug safely lowers cholesterol levels to a healthy target within 3 to 6 months. The approach was to add atorvastatin to their regular care to manage a common complication of their kidney condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institute of kidney diseases and Urology
Dhaka, Dhaka Division, 1207, Bangladesh
Conditions
Explore the condition pages connected to this study.